Brazil expands foreign medtech GMP inspections capacity: reactive or proactive?
This article was originally published in Clinica
Executive Summary
Brazil's regulatory agency Anvisa is now able to authorise staff of state- or municipal-controlled centres to conduct inspections abroad of import licensees, on behalf of the national healthcare vigilance system (SNVS).